Chief Medical Officer at ViiV Healthcare
ViiV Advances Long-Acting HIV Care with Patient-Led Strategy
At IAS 2025, ViiV’s Jean van Wyk, MBChB, MFPM, shares how real-world data and patient priorities are guiding a new era of HIV care.
Read More
Long-Acting HIV Therapy Gains Ground in Both New and Experienced Patients
At IAS 2025, the VOLITION and OPERA study data show patient preference and real-world use of injectable CAB + RPV LA, informing the treatment strategy of ViiV CMO Jean van Wyk.